- Home
- CLDI vs ARTW Comparison
CLDI vs ARTW Comparison
Compare CLDI & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- ARTW
- Stock Information
- Founded
- CLDI 2014
- ARTW 1956
- Country
- CLDI United States
- ARTW United States
- Employees
- CLDI N/A
- ARTW N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- ARTW Industrial Machinery/Components
- Sector
- CLDI Health Care
- ARTW Industrials
- Exchange
- CLDI Nasdaq
- ARTW Nasdaq
- Market Cap
- CLDI 20.2M
- ARTW 23.5M
- IPO Year
- CLDI N/A
- ARTW N/A
- Fundamental
- Price
- CLDI $1.62
- ARTW $2.92
- Analyst Decision
- CLDI
- ARTW
- Analyst Count
- CLDI 0
- ARTW 0
- Target Price
- CLDI N/A
- ARTW N/A
- AVG Volume (30 Days)
- CLDI 485.8K
- ARTW 57.1K
- Earning Date
- CLDI 11-11-2025
- ARTW 10-03-2025
- Dividend Yield
- CLDI N/A
- ARTW N/A
- EPS Growth
- CLDI N/A
- ARTW N/A
- EPS
- CLDI N/A
- ARTW 0.44
- Revenue
- CLDI N/A
- ARTW $23,523,353.00
- Revenue This Year
- CLDI N/A
- ARTW N/A
- Revenue Next Year
- CLDI N/A
- ARTW N/A
- P/E Ratio
- CLDI N/A
- ARTW $8.40
- Revenue Growth
- CLDI N/A
- ARTW N/A
- 52 Week Low
- CLDI $1.51
- ARTW $1.43
- 52 Week High
- CLDI $46.68
- ARTW $4.71
- Technical
- Relative Strength Index (RSI)
- CLDI 30.80
- ARTW 43.08
- Support Level
- CLDI $1.51
- ARTW $3.00
- Resistance Level
- CLDI $1.68
- ARTW $3.27
- Average True Range (ATR)
- CLDI 0.12
- ARTW 0.27
- MACD
- CLDI 0.13
- ARTW -0.05
- Stochastic Oscillator
- CLDI 28.38
- ARTW 3.60
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.